Companion Animal – Antibiotics
ORBAX® Tablets
Product Description
ORBAX® (Orbifloxacin) Tablets are for the management of diseases in dogs associated with bacteria that is susceptible to orbifloxacin.
| Product Name | Pkg Size | GTIN#/UPC# | UIN# |
|---|---|---|---|
| ORBAX® Tablets | 22.7 mg x 250 | 300611141018 | 058809 |
| ORBAX® Tablets | 68 mg x 100 | 300611174016 | 058811 |
Important Safety Information:
Quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. Orbifloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. In animals with known or suspected central nervous system (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation, which may lead to convulsive seizures. The use of fluoroquinolones in cats has been reported to adversely affect the retina and should be used with caution in cats. Blindness has also been reported post-approval in cats. In some cases, blindness has been temporary. See Package Insert for full information including side effects, precautions, warnings and contraindications.